Single Human Embryo Transfer in Assisted Reproduction Programs (SET)

November 15, 2011 updated by: Inmaculada Molina Botella, Fundacion Para La Investigacion Hospital La Fe

Single Human Embryo Transfer: Comparison of Morphologic and Morphometric Parameters for Day 2 Embryo Selection Before Transference.

Embryo selection based on the use of morphometric parameters should increase the implantation success rate.

One of the most important issues of "Assisted Reproduction Technologies (ART)" is the possibility of multiple pregnancies which carries a significant risk for maternal-fetal health. These risks can be reduced by restricting the number of embryos transferred.

To do this, it is essential to improve current techniques of embryo selection by developing new tools that would allow the selection of the embryos with higher implantation potential. In previous works (Molina et al 2011) the investigators have demonstrated greater efficacy for the embryo classification systems based on the use of the morphometric variables. The investigators have also developed a profile of embryo implantation using these morphometric variables. In this project the investigators intend to validate the clinical validity of this new embryo classification system by conducting a prospective study of single embryo transfer (SET) in young women at risk of multiple pregnancies.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

154

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Valencia, Spain, 46009
        • Recruiting
        • Hospital Universitari La Fe
        • Contact:
        • Sub-Investigator:
          • Montañana Vicente, Ph.D
        • Sub-Investigator:
          • Martinez Juan Vicente
        • Sub-Investigator:
          • Rubio Jose Maria, Ph.D
        • Sub-Investigator:
          • Polo Patrocinio, Ph.D
        • Sub-Investigator:
          • Balasch Sebastian, Ph.D
        • Sub-Investigator:
          • Garcia Trinidad, Ph.D
        • Sub-Investigator:
          • Marzal Alicia
        • Sub-Investigator:
          • Taronger Roser, Ph.D

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Personal and family history without interest, not toxic habits.
  • Less than 35 years at the time of IVF-ICSI cycle
  • Sterility of unknown origin or tubal obstruction.

Exclusion Criteria:

  • Repeat nonvoluntary abortions
  • Endometriosis
  • Polycystic ovary syndrome (criteria Rotterdam 2004)
  • Severe male factor (REM <1 million sperm / ml)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: single embryo transfer
Prospective study of single embryo transfers in selected women with good reproductive prognosis and high risk of multiple pregnancies in an IVF-ICSI program.. The day of the embryo transfer, the patients will be randomized by a computer application for morphological and morphometric embryo selection.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implantation rate
Time Frame: 6 weeks after the embryo transference
Pregnancy was defined as a gestational sac with a foetus with heart activity detected through sonography in gestational week 6-8.The implantation rate was defined as the number of gestational sacs per number of transferred embryos.
6 weeks after the embryo transference

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Morphologic embryo selection
Time Frame: 48 hours post insemination (day 2)
The morphological selection will be made by direct observation of the embryo in an inverted microscope phase contrast. Cell number, blastomere symmetry and fragmentation, and structural abnormalities of the zona pellucida (ZP)were recorded
48 hours post insemination (day 2)
Morphometric embryo selection
Time Frame: 48 hours post insemination (day 2)
Morphometric selection will be made by obtaining serial photographs of the embryo that will later be analyzed with an image analysis program that will select the best quality embryos for later transfer The images were analyzed by using ImageJ, a public program developed by Wayne Rasband (http://rsb.info.nih.gov/ij/) and their available tools. The program was used interactively, by applying several of tools and plugins in order to determine the region of interest for the measurements.
48 hours post insemination (day 2)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Jose J Pertusa, Ph.D., Director of the deparment of Biología Funcional y Análisis de Imagen
  • Study Director: Antonio A Pellicer, Ph.D., Head of Gynecology and Obstetrics
  • Principal Investigator: Inmaculada I Molina, Ph.D., Embryologist of the Human Reproduction Unit

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2011

Primary Completion (Anticipated)

December 1, 2013

Study Completion (Anticipated)

June 1, 2014

Study Registration Dates

First Submitted

November 9, 2011

First Submitted That Met QC Criteria

November 15, 2011

First Posted (Estimate)

November 16, 2011

Study Record Updates

Last Update Posted (Estimate)

November 16, 2011

Last Update Submitted That Met QC Criteria

November 15, 2011

Last Verified

November 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • 2011/0329

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multiple Pregnancies

Clinical Trials on Single embryo transfer in women at risk of multiple pregnancies

3
Subscribe